51 – 92 of 92
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2018
-
Mark
Breast cancer screening with tomosynthesis - Distribution of cancer subtypes in the Malmö Breast Tomosynthesis Screening Trial
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)
(
- Contribution to journal › Published meeting abstract
-
Mark
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
(
- Contribution to journal › Article
-
Mark
Myoepithelium assessment with p63 immunostaining in formalinfixed paraffin-embedded breast cancer tissue pre-treated with RNA-later
(
- Contribution to journal › Published meeting abstract
-
Mark
p53 maintains baseline expression of multiple tumor suppressor genes
(
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
- 2016
-
Mark
PTEN and NEDD4 in Human Breast Carcinoma.
(
- Contribution to journal › Article
-
Mark
The state of the art in prediction of breast cancer relapse using cell-free circulating tumor DNA liquid biopsies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
-
Mark
TopHat-Recondition : A post-processor for TopHat unmapped reads
(
- Contribution to journal › Article
-
Mark
Apparent exchange rate for breast cancer characterization.
(
- Contribution to journal › Article
- 2015
-
Mark
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.
(
- Contribution to journal › Article
-
Mark
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
-
Mark
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells
(
- Contribution to journal › Article
- 2012
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
-
Mark
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
- 2009
-
Mark
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma
(
- Contribution to journal › Article
-
Mark
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a
(
- Contribution to journal › Article
- 2008
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
-
Mark
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
(
- Contribution to journal › Article
- 2007
-
Mark
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
(
- Contribution to journal › Article
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
- 2006
-
Mark
An introduction to BioArray software environment
(
- Contribution to journal › Scientific review
- 2005
-
Mark
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
(
- Contribution to journal › Article
-
Mark
Estrogen receptor (ER)-beta has favorable independent prognostic value for ER-alfa negative breast cancer patients receiving adjuvant tamoxifen
(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
Bioarray software environment: a platform for comprehensive management and analysis of microarray data
(
- Contribution to journal › Article
-
Mark
Gene expression profiling in cancer using cDNA microarrays
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
(
- Contribution to journal › Article
-
Mark
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
(
- Contribution to journal › Article
- 1999
-
Mark
Expression profiling in cancer using cDNA microarrays
(
- Contribution to journal › Scientific review
-
Mark
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »